Zolpidem Tartrate
Product Images NDC 40032-761

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 40032-761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novel Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (8803cf1f 08be 409e B37e C83a0313fcbc 01)

Chemical structure diagram of Zolpidem Tartrate showing two molecular components, including the Zolpidem moiety and the tartrate moiety, depicted with ring and chain structures and various functional groups.*

FDA Label Image

A (8803cf1f 08be 409e B37e C83a0313fcbc 02)

An instructional illustration showing a person resting their head on a pillow with their arm raised. A clock and a card labeled "only 1 pouch" are placed on a nearby surface. The image is labeled as Figure A, likely demonstrating use or timing related to the product Zolpidem Tartrate.*

FDA Label Image

B (8803cf1f 08be 409e B37e C83a0313fcbc 03)

A table titled 'Figure B' showing times to take Zolpidem Tartrate Sublingual Tablets before desired awake times. It lists awake times from 4 am to 9 am with corresponding sublingual tablet times from 12 midnight to 5 am, indicating timing guidance for administration relative to waking.*

FDA Label Image

C (8803cf1f 08be 409e B37e C83a0313fcbc 04)

Instructional diagram for Zolpidem Tartrate Sublingual Tablet showing how to use a dosing wheel to find the latest dosing time. It includes instructions to turn the wheel to align with the earliest time to be awake and to take the tablet before the indicated time under a black arrow, with a note about waiting at least 4 hours after bedtime before dosing.*

FDA Label Image

D (8803cf1f 08be 409e B37e C83a0313fcbc 05)

An instructional illustration labeled Figure D showing two hands opening a rectangular blister or strip package, with one hand holding the package and the other pulling back a flap or cover.*

FDA Label Image

E (8803cf1f 08be 409e B37e C83a0313fcbc 06)

An instructional illustration labeled 'Figure E' showing a person using scissors to cut a small rectangular object, possibly a blister pack or similar packaging. The image focuses on the cutting action performed by two hands, one holding the scissors and the other holding the item to be cut.*

FDA Label Image

F (8803cf1f 08be 409e B37e C83a0313fcbc 07)

An illustration showing a hand pulling an empty pouch from a surface with a clock in the background, labeled as Figure F. The image appears instructional, depicting a timing or removal action related to the pouch.*

FDA Label Image

G (8803cf1f 08be 409e B37e C83a0313fcbc 08)

An instructional illustration showing a hand placing a tablet or pill into an open mouth. It depicts the action of oral administration of medication, labeled as Figure G.*

FDA Label Image

1.75-car-1 (8803cf1f 08be 409e B37e C83a0313fcbc 09)

Box packaging label for Zolpidem Tartrate 1.75 mg sublingual tablets by Novel Laboratories, Inc. It contains 30 unit-dose pouches with one sublingual tablet each. The label includes dosage form and strength, dispensing instructions, and manufacturer information from Somerset, NJ.*

FDA Label Image

1.75-car-2 (8803cf1f 08be 409e B37e C83a0313fcbc 10)

Packaging label for Zolpidem Tartrate 1.75 mg sublingual tablets by Novel Laboratories, Inc. The label indicates each pouch contains one sublingual tablet, with 30 unit-dose pouches per package. The label includes usage instructions, storage conditions, and a barcode. The product is designated Rx only with a controlled substance Schedule IV symbol.*

FDA Label Image

3.5-car-1 (8803cf1f 08be 409e B37e C83a0313fcbc 11)

Packaging label for Zolpidem Tartrate Sublingual Tablet 3.5 mg from Novel Laboratories, Inc. The label shows the product name, strength, dosage form as sublingual tablet, and indicates 30 unit-dose pouches per package. Additional text advises sublingual administration only and contains pharmacist instructions and manufacturer information.*

FDA Label Image

3.5-car-2 (8803cf1f 08be 409e B37e C83a0313fcbc 12)

Zolpidem Tartrate 3.5 mg sublingual tablet packaging label from Novel Laboratories, Inc. The label indicates 30 unit-dose pouches, each containing one sublingual tablet. The label emphasizes sublingual administration and includes warnings not to swallow the tablet whole. The label features the Schedule IV (C-IV) controlled substance symbol.*

FDA Label Image

1.75-pouch (8803cf1f 08be 409e B37e C83a0313fcbc 13)

Zolpidem Tartrate Sublingual Tablet 1.75 mg label from Novel Laboratories, Inc. The package features directions for adult dosage, sublingual administration instructions, and a dosing time chart. It includes warnings not to swallow the tablet whole and storage instructions. The label also contains an NDC code 40032-762-01 and identifies the product as spearmint flavored.*

FDA Label Image

3.5-pouch (8803cf1f 08be 409e B37e C83a0313fcbc 14)

Zolpidem Tartrate Sublingual Tablet 3.5 mg packaging label from Novel Laboratories, Inc. The label specifies this is a controlled substance (schedule IV) sublingual tablet for single use, with instructions emphasizing sublingual administration only, not swallowing whole. It contains one spearmint-flavored tablet per package and includes dosage information, storage instructions, and a dosing time chart for use.*

FDA Label Image

1.75-blister (8803cf1f 08be 409e B37e C83a0313fcbc 15)

Label for Zolpidem Tartrate 1.75 mg sublingual tablets by Novel Laboratories, Inc. The label includes an NDC number (40032-762-01), instructions to cut the blister at the dotted line with scissors to remove the tablet, and standard lot/expiration placeholders. The design features a prominent dosage strength and a schedule IV control symbol (C IV).*

FDA Label Image

3.5-blister (8803cf1f 08be 409e B37e C83a0313fcbc 16)

Zolpidem Tartrate sublingual tablet 3.5 mg packaging label showing the product name, dosage strength, dosage form, and a Schedule IV controlled substance symbol. Label includes instructions to cut blister with scissors at the dotted line to remove the tablet. Manufactured by Novel Laboratories, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.